Advocacy intelligence hub — real-time data for patient organizations
BioRay Pharmaceutical Co., Ltd. — PHASE2
Diakonhjemmet Hospital — NA
Innovent Biologics Technology Limited (Shanghai R&D Center) — PHASE3
Chang Gung University of Science and Technology — NA
Örebro University, Sweden — NA
Atom Therapeutics Co., Ltd — PHASE1
Zhu Xiaoxia — NA
Protalix — PHASE2
Massachusetts General Hospital — PHASE4
XueMei Guo — NA
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Mikhail Samsonov
R-Pharm
William L Nyhan, MD
University of California, San Diego
Kathleen Butler, MD
Incyte Corporation
Tristan Pascart, MD
Hospital Group of the Catholic Institute of Lille
Rodrigo Suarez-Otero, MD
SMIQ, S. De. R.L. de C.V. (Grupo Cien y ético de Querétaro)
Rafael Lanuza-Ramirez, MD
Consultorio Médico "Dr. Rodrigo Suárez Otero"